Fungal Infections in Immunocompromised Hosts

Kontoyiannis, Dimitrios P.; Slavin, Monica

doi:10.3390/books978-3-03897-717-9

Download Url(s)

https://mdpi.com/books/pdfview/book/1195

Author(s)

Kontoyiannis, Dimitrios P.

Slavin, Monica

Language

English

Show full item record

Abstract

This book is a printed edition of the Special Issue Fungal Infections in Immunocompromised Hosts that was published in JoF

URI

https://directory.doabooks.org/handle/20.500.12854/48211

Keywords

toxicity; risk assessment; species complex; galactomannan; taxonomy; Aspergillus PCR; candidemia; adaptive immunity; fungal immunity; T2 Candida; anti-fungal agents; innate immunity; antifungal stewardship; Immunotherapy; Candida meningoencephalitis; liposomal amphotericin B; anidulafungin; liver disease; invasive mold disease; T2Candida; AIDS; (1?3)-?-d-glucan; literature review; yeast; hepatic impairment; prediction models; IRIS; invasive aspergillosis; antifungal agent; TNF inhibitors; Aspergillus fumigatus; fungal nomenclature; micafungin; non-culture-based diagnostics; PCR; paracoccidioidomycosis; Candida auris; multidrug resistance; subcutaneous mycoses; risk score; mycoses of implantation; Sporothrix brasiliensis; antifungal resistance; immunocompromised hosts; Sporothrix schenckii; Aspergillus; fungus; cell therapy; MALDI-ToF MS; lateral flow; phylogenetics; hematological malignancy; candidiasis; antifungal drug; hematological malignancies; mycoses; invasive fungal infections; lymphoma; kidney transplant; immune reconstitution inflammatory syndrome; mechanisms of antifungal resistance; fungal infections; cytokine therapy; sporotrichosis; beta-d-glucan; invasive fungal infection; HIV; cat-transmitted sporotrichosis; aspergillosis; cancer; prognostic risk model